Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways

BACKGROUND/PURPOSE: Prostate cancer is a major burden on public health and a major cause of morbidity and mortality among men worldwide. Drug combination therapy is known as a powerful tool for the treatment of cancer. The aim of this study is to evaluate the synergistic inhibitory mechanisms of clo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Lixia, He, Zhenglei, Head, Sarah A, Zhou, Yinghui, Lu, Ting, Feng, Xulong, Zhang, Xueqing, Zhang, Meng, Dang, Yongjun, Jiang, Xinghong, Wang, Minghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205540/
https://www.ncbi.nlm.nih.gov/pubmed/30425575
http://dx.doi.org/10.2147/CMAR.S175256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205540/
https://www.ncbi.nlm.nih.gov/pubmed/30425575
http://dx.doi.org/10.2147/CMAR.S175256

Ejemplares similares